Furthermore, the combination of metformin with thiazolidinediones is a promising novel therapy for restoring menstrual regularity, but this combination may be less effective in obesity management when compared to the metformin-GLP-1 combination [35,71]. This evidence concerns the gene GLP1R and obesity due to melanocortin 4 receptor deficiency.